Bausch Health Companies reported $9M in Interest Income for its fiscal quarter ending in December of 2025.





Interest Income Change Date
Aurora Cannabis CAD 1.85M 120K Sep/2025
Bausch Health Companies USD 9M 6M Dec/2025
Biogen USD 37.9M 700K Mar/2026
Corcept Therapeutics USD 5.42M 399K Dec/2025
Danaher USD 27M 14M Mar/2026
Drreddys Laboratories INR 796M 332M Dec/2025
Eli Lilly USD 65M 25M Sep/2025
Gilead Sciences USD 95M 7M Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pacira USD 2.3M 6.24M Dec/2025
Phibro Animal Health USD 0.08 0.09 Dec/2024
Supernus Pharmaceuticals USD 2.02M 254K Dec/2025
Vertex Pharmaceuticals USD 114.8M 7.1M Mar/2026
Zoetis USD 25M 1000K Dec/2025